Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial
Tallennettuna:
Defulio, A., ET AL., Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial. Drug and Alcohol Dependence, Vol. 121, no. 1-3 (2012), p. 48-54.
Ref.
185763
Sijainti:
SIIS R.854 Archivo
Palabras clave:
Cocaína, Datos estadísticos, Drogodependencias, Heroína, Naltrexona, Opiáceos, Patrones de consumo, Programas de mantenimiento, Tratamiento médico, EE.UU.
Cocaína, Datos estadísticos, Drogodependencias, Heroína, Naltrexona, Opiáceos, Patrones de consumo, Programas de mantenimiento, Tratamiento médico, EE.UU.
Samankaltaisia teoksia: Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled trial
- Employment based reinforcement of adherence to depot naltrexone in unemployed opioid dependent adults: a randomized controlled trial
- Interest in extended release naltrexone among opioid users
- Extended-release naltrexone for alcohol and opioid problems in missouri parolees and probationers
- Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
- Extended-release naltrexone for alcohol and opioid dependence: A meta-analysis of healthcare utilization studies
- EXTENDED-RELEASE NALTREXONE FOR TREATMENT OF ALCOHOL DEPENDENCE IN PRIMARY CARE